Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Harmen J G van de Werken
Affiliation
Department of Immunology Erasmus University Medical Center
ORCID
Career Start Year
2006
Papers
78
H Index
31
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38063488
TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model.
J Immunol
2024
36932139
Evaluation of pre-processing methods for tear fluid proteomics using proximity extension assays.
Sci Rep
2023
38083327
Classification of Inflammation of Unknown Origin patients based on RNA-seq and SomaScan data.
Annu Int Conf IEEE Eng Med Biol Soc
2023
37735204
Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition.
Sci Rep
2023
37771591
Ibrutinib directly reduces CD8+T cell exhaustion independent of BTK.
Front Immunol
2023
37158243
Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients.
Hepatology
2023
37400554
The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies.
Sci Rep
2023
36621142
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors.
Biomed Pharmacother
2023
34608482
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis.
Neuro Oncol
2022
37848617
Katdetectr: an R/bioconductor package utilizing unsupervised changepoint analysis for robust kataegis detection.
Gigascience
2022
35442716
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors.
J Clin Oncol
2022
35662281
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests.
Oncogene
2022
35860283
Trained Immunity in Primary Sjögren's Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype.
Front Immunol
2022
35717359
Reply to Yuxuan Song, Caipeng Qin, and Tao Xu's Letter to the Editor re: J. Alberto Nakauma-González, Maud Rijnders, Job van Riet, et al. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma. Eur Urol 2022;81:331-6.
Eur Urol
2022
36429059
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling.
Cells
2022
33596640
The miR-200c/141-ZEB2-TGFβ axis is aberrant in human T-cell prolymphocytic leukemia.
Haematologica
2022
35159112
Identification of Early-Onset Metastasis in SF3B1 Mutated Uveal Melanoma.
Cancers (Basel)
2022
35177626
Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning.
Nat Commun
2022
35086719
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma.
Eur Urol
2022
35022662
Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
Rheumatology (Oxford)
2022
34864882
ProteoDisco: a flexible R approach to generate customized protein databases for extended search space of novel and variant proteins in proteogenomic studies.
Bioinformatics
2022
33006377
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
Int J Cancer
2021
33811251
Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
Sci Rep
2021
34891161
Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA-minus RNA sequencing data.
Gigascience
2021
35047820
Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas.
Neurooncol Adv
2021
34724897
FASTAFS: file system virtualisation of random access compressed FASTA files.
BMC Bioinformatics
2021
34749299
Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer.
EBioMedicine
2021
34326338
The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets.
Nat Commun
2021
34036938
Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer.
Elife
2021
33932725
Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Eur J Cancer
2021
32163234
Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.
Stem Cells Transl Med
2020
32057596
Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review.
Urol Oncol
2020
33427690
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.
J Immunother Cancer
2020
30672466
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells.
Elife
2019
35100672
Unique Case of a Rare Mesenchymal Tumor Harboring a Somatic c.119delC <i>VHL</i> Mutation.
JCO Precis Oncol
2019
31748536
The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.
Nat Commun
2019
30257989
Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
Mol Cancer Res
2019
31570896
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies.
Nat Genet
2019
31425584
Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients.
Invest Ophthalmol Vis Sci
2019
31043383
Correction: Functional <i>Ex Vivo</i> Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects.
Clin Cancer Res
2019
29305224
SNPitty: An Intuitive Web Application for Interactive B-Allele Frequency and Copy Number Visualization of Next-Generation Sequencing Data.
J Mol Diagn
2018
29914715
Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint Signatures.
Eur Urol
2018
30157426
Paneth Cells Respond to Inflammation and Contribute to Tissue Regeneration by Acquiring Stem-like Features through SCF/c-Kit Signaling.
Cell Rep
2018
29929481
Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons.
BMC Bioinformatics
2018
30139880
Functional <i>Ex Vivo</i> Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects.
Clin Cancer Res
2018
29419817
Investigation of the spatial structure and interactions of the genome at sub-kilobase-pair resolution using T2C.
Nat Protoc
2018
27916271
Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.
Ophthalmology
2017
28319171
A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.
PLoS One
2017
28341771
Small chromosomal regions position themselves autonomously according to their chromatin class.
Genome Res
2017
28683324
DOC1-Dependent Recruitment of NURD Reveals Antagonism with SWI/SNF during Epithelial-Mesenchymal Transition in Oral Cancer Cells.
Cell Rep
2017
1 - 50 of 78
Column Actions
Search
Recommended Authors
Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year
2016
Number of shared co-authors
4
Marc Dabad
Universitat de Barcelona (UB)
Career Start Year
2013
Number of shared co-authors
6
Marta Gut
Universitat de Barcelona (UB)
Career Start Year
2010
Number of shared co-authors
9
Venkat S Malladi
UT Southwestern Medical Center
Career Start Year
2008
Number of shared co-authors
4
Jonathan E Bard
University at Buffalo
Career Start Year
2007
Number of shared co-authors
0
Raj Chari
The National Institutes of Health
Career Start Year
2006
Number of shared co-authors
2
Xiaotu Ma
St. Jude Children's Research Hospital
Career Start Year
2006
Number of shared co-authors
1
Altuna Akalin
Berlin Institute for Medical Systems Biology
Career Start Year
2006
Number of shared co-authors
3
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year
2006
Number of shared co-authors
7
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
0
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Career Start Year
2005
Number of shared co-authors
4
Christoph Bock
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year
2005
Number of shared co-authors
12
Matthias Schlesner
University of Augsburg
Career Start Year
2004
Number of shared co-authors
8
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year
2003
Number of shared co-authors
1
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
5
Osvaldo Gra??a
Spanish National Cancer Research Centre-CNIO
Career Start Year
2002
Number of shared co-authors
2
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
6
Peter J Park
Harvard Medical School
Career Start Year
2001
Number of shared co-authors
3
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year
2001
Number of shared co-authors
0
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year
1999
Number of shared co-authors
0
Martin Hirst
University of British Columbia
Career Start Year
1998
Number of shared co-authors
5
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Career Start Year
1998
Number of shared co-authors
2
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year
1997
Number of shared co-authors
10
Steven J M Jones
University of British Columbia
Career Start Year
1995
Number of shared co-authors
8
Marco A Marra
University of British Columbia
Career Start Year
1993
Number of shared co-authors
6
Jean-Pierre A Kocher
Mayo Clinic
Career Start Year
1991
Number of shared co-authors
0
Aleksandar Milosavljevic
Baylor College of Medicine
Career Start Year
1991
Number of shared co-authors
2
Elaine R Mardis
The Ohio State University
Career Start Year
1988
Number of shared co-authors
4
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year
1987
Number of shared co-authors
7
row(s) 1 - 30 of 30
Collaborators
Job van Riet
Erasmus MC Cancer Institute
Co-authored papers
22
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers
10
Martijn P Lolkema
Erasmus MC Cancer Institute
Co-authored papers
9
Edwin Cuppen
Hartwig Medical Foundation
Co-authored papers
8
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Co-authored papers
6
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers
6
Guido Jenster
Erasmus University Medical Center
Co-authored papers
6
Youri Hoogstrate
Erasmus MC Cancer Institute
Co-authored papers
5
Pim J French
Erasmus MC Cancer Institute
Co-authored papers
4
Ronald de Wit
Erasmus MC Cancer Institute
Co-authored papers
4
Emile E Voest
The Netherlands Cancer Institute
Co-authored papers
3
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Co-authored papers
3
Paul Hamberg
Franciscus Gasthuis & Vlietland Hospital Rotterdam and Schiedam
Co-authored papers
3
Neeltje Steeghs
Netherlands Cancer Institute-Antoni Van Leeuwenhoek
Co-authored papers
3
Jeroen A A Demmers
Erasmus Medical Center
Co-authored papers
3
Hans Clevers
Princess Maxima Center for Pediatric Oncology
Co-authored papers
2
Lisanne F van Dessel
Erasmus MC Cancer Institute
Co-authored papers
2
Kristian Helin
The Institute of Cancer Research
Co-authored papers
2
Michiel S van der Heijden
the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
Co-authored papers
2
Niven Mehra
Radboud university medical center
Co-authored papers
2
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Co-authored papers
2
Jochen D Muehlschlegel
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers
1
Zhen Ye
Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers
1
Paul J van Diest
University Medical Center Utrecht
Co-authored papers
1
Katja K H Aben
Co-authored papers
1
Reiner Siebert
Co-authored papers
1
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Co-authored papers
1
Albin Sandelin
University of Copenhagen
Co-authored papers
1
Marc van de Wetering
Princess Maxima Center for Pediatric Oncology
Co-authored papers
1
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers
1
1 - 30